EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Rectal Gastrointestinal Stromal Tumor Complicated by Tumor Lysis Syndrome after Imatinib Initiation: A Rare and Fatal Case

Cyrine Louati, Karima Tlili, Asma Dahmane, Faten Gargouri, Nada Mansouri, Issam Msakni

Case Reports in Gastroenterology · 2026-03-06 · 20 (1) · 92-99

DOI: 10.1159/000550905 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Gastrointestinal stromal tumors (GISTs) are rare mesenchymal connective tumors. They generally develop from the gastric or intestinal wallor. Rectal location is rare. In fact, rectal GISTs account for 5% of cases and 0.1% of all rectal tumors. Case Presentation: We report the case of a stromal tumor of rectal localization in order to study the clinical, anatomopathological and radiological particularities of this entity. We report the case of a 73-year-old patient who was initially admitted for a stent placement. A rectoscopy showed a half circumferential rectal process. It was situated at 2 cm from the anal verge. The magnetic resonance imaging of the pelvis showed a large tumor of the lower rectum, with a focal rupture of the right rectal wall and invading the sphincter apparatus. Pathological examination revealed a proliferation of spindle-shaped cells with abundant cytoplasm and ovoid atypical nuclei with a high mitotic index. The immunohistochemical study showed that the tumor cells were positive for CKit and DOG1 and negative for AML and PS100. The retained diagnosis was high-risk spindle cell GIST. Conclusion: Rectal GISTs are rare tumors. Diagnosis is based on anatomopathological examination with immunohistochemical study. Surgical resection is the standard treatment for localized GIST. Imatinib is the first-line prescribed treatment, with particular attention to potentially life-threatening adverse effects.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →